Abbott Spinoff May Fetch $54 Billion as Humira Tempts Rivals

Abbott Spinoff May Fetch $54 Billion as Humira Tempts Rivals

JB Reed/Bloomberg

Tablets of Abbott Laboratories' cholesterol drug TriCor.